Interference in Immunoassay

FIGURE I. Stylized diagram of the immunoglobulin molecule showing derivation of the various fragments used for preparation of antibodies in immunoassay. Immunoassays are a form of macromolecular binding reaction; no covalent chemical bonding is involved. Antibodies interact with their antigens by weak hydrogen bonding and van der Waals forces. Antigen-antibody reactions are dependent on complementary matching shapes (i.e. structural conformity) being assumed by the antibody variable (Fab) regions (see Fig. I) of the immunoglobulin. Almost all polyclonal antibodies used in immunoassay reactions are of the immunoglobulin G (IgG) class. The N-terminal 110 amino acid residues of both the heavy and light chains of the immunoglobulin molecules are variable in sequence and interact to form the antigen binding site. About 30 amino acids are potentially available as antigen contact residues, but X-ray crystallographic studies have shown that a maximum of only 17 amino acids are directly involved in binding contact. Nevertheless, this variability gives rise to a vast array of different

[1]  U. Feldt-Rasmussen,et al.  Analytical and clinical performance goals for testing autoantibodies to thyroperoxidase, thyroglobulin, and thyrotropin receptor. , 1996, Clinical chemistry.

[2]  J. E. Midgley,et al.  Concentrations of free thyroxin and albumin in serum in severe nonthyroidal illness: assay artefacts and physiological influences. , 1990, Clinical chemistry.

[3]  L. Demers Monoclonal antibodies to lutropin: are our immunoassays too specific? , 1991, Clinical Chemistry.

[4]  J. E. Rall,et al.  An unusual instance of thyroxine-binding by human serum gamma globulin. , 1956, The Journal of clinical endocrinology and metabolism.

[5]  G. S. Wilson,et al.  Studies of the low dose 'hook' effect in a competitive homogeneous immunoassay. , 1992, Journal of immunological methods.

[6]  Endo Yuichi,et al.  Use of inorganic salts to minimize serum interference in a sandwich enzyme immunoassay for human growth hormone using Fab'-horseradish peroxidase conjugate. , 1983 .

[7]  P. Kirkpatrick,et al.  Thyroid-function testing with the TDx: interference from endogenous fluorophore. , 1987, Clinical chemistry.

[8]  T. Weber,et al.  Endogenous interference in immunoassays in clinical chemistry. A review. , 1990, Scandinavian journal of clinical and laboratory investigation. Supplementum.

[9]  R. Ahsan,et al.  Serum Binding of Steroid Tracers and its Possible Effects on Direct Steroid Immunoassay , 1995, Annals of clinical biochemistry.

[10]  A. Collins XENOGENEIC ANTIBODIES AND ATOPIC DISEASE , 1988, The Lancet.

[11]  J. S. Woodhead,et al.  Fenclofenac and Thyroid Function Tests , 1983, Annals of clinical biochemistry.

[12]  T. Visser,et al.  RAISED TOTAL THYROXINE AND FREE THYROXINE INDEX BUT NORMAL FREE THYROXINE A Serum Abnormality due to Inherited Increased Affinity of Iodothyronines for Serum Binding Protein , 1979, The Lancet.

[13]  J. Canick,et al.  The effect of smoking in pregnancy on maternal serum alpha‐fetoprotein, unconjugated oestriol, human chorionic gonadotrophin, progesterone and dehydroepiandrosterone sulphate levels , 1990, British journal of obstetrics and gynaecology.

[14]  P. Oehr,et al.  Evidence for interaction of human anti-idiotypic antibodies with CA 125 determination in a patient after radioimmunodetection. , 1990, Clinical chemistry.

[15]  C. West,et al.  The Long-Term Stability in Whole Blood of 14 Commonly-Requested Hormone Analytes , 1994, Annals of clinical biochemistry.

[16]  P. Kenemans,et al.  Heterophilic antibodies in human sera causing falsely increased results in the CA 125 immunofluorometric assay. , 1990, Clinical chemistry.

[17]  J. Gosling A decade of development in immunoassay methodology. , 1990, Clinical chemistry.

[18]  H. van Toor,et al.  Free thyroxine assessed with three assays in sera of patients with nonthyroidal illness and of subjects with abnormal concentrations of thyroxine-binding proteins. , 1993, Clinical chemistry.

[19]  R. A. Jackson,et al.  Misleading results from immunoassays of serum free thyroxine in the presence of rheumatoid factor. , 1997, Clinical chemistry.

[20]  N. Lawson,et al.  Measurement of Urinary Free Cortisol Using the ACS:180 Serum Cortisol Chemiluminescent Immunoassay , 2000, Annals of clinical biochemistry.

[21]  J. Ladenson,et al.  Endogenous serum antibodies that interfere with a common thyroid hormone uptake assay: characterization and prevalence. , 1994, Clinical chemistry.

[22]  M. McConway,et al.  Specificity of Two-Site Immunometric Assays , 1991, Annals of clinical biochemistry.

[23]  A. Wallace Analytical Support for the Detection and Treatment of Congenital Adrenal Hyperplasia , 1995, Annals of clinical biochemistry.

[24]  G. S. Wilson,et al.  Multiple epitope interactions in the two-step sandwich immunoassay. , 1992, Journal of immunological methods.

[25]  F. Clark,et al.  Spuriously high free thyroxine with the Amerlite MAB FT4 assay. , 1994, Journal of clinical pathology.

[26]  C. Migeon,et al.  Assay of plasma testosterone during the first six months of life: importance of chromatographic purification of steroids. , 1995, Clinical chemistry.

[27]  M. Wheeler,et al.  The Role of Testosterone Measurement in the Investigation of Androgen Disorders , 1986, Annals of clinical biochemistry.

[28]  C. P. Reilly,et al.  Critical Assessment of the Amerlite Free T4 Assay , 1989, Annals of clinical biochemistry.

[29]  M H Kroll,et al.  Interference with clinical laboratory analyses. , 1994, Clinical chemistry.

[30]  César Milstein,et al.  Man-made antibodies , 1991, Nature.

[31]  E. Nickoloff Interference in immunoassay. , 1984, Critical reviews in clinical laboratory sciences.

[32]  J. E. Midgley,et al.  One-step, labeled-antibody assay for measuring free thyroxin. I. Assay development and validation. , 1992, Clinical chemistry.

[33]  C. Spencer,et al.  Current status and performance goals for serum thyroglobulin assays. , 1996, Clinical chemistry.

[34]  I. Laing,et al.  Differences in Serum Luteinizing Hormone Measurements by Immunoradiometric Assay Induced by Kinetic Manipulation of Assay Conditions are Dependent on the Endocrine Milieu of Serum , 1996, Annals of clinical biochemistry.

[35]  J. Keffer Preanalytical considerations in testing thyroid function. , 1996, Clinical chemistry.

[36]  D. Topliss,et al.  Familial euthyroid thyroxine excess: an appropriate response to abnormal thyroxine binding associated with albumin. , 1981, The Journal of clinical endocrinology and metabolism.

[37]  S. Baudner Measurement signal versus value in immunoassays for human plasmaproteins. , 1991, Scandinavian journal of clinical and laboratory investigation. Supplementum.

[38]  G. S. Wilson,et al.  Studies of the 'hook' effect in the one-step sandwich immunoassay. , 1992, Journal of immunological methods.

[39]  F. Singer,et al.  Measurement of parathyroid hormone. , 1989, Endocrinology and metabolism clinics of North America.

[40]  W. Jäger,et al.  Human anti-mouse antibodies against OC-125 do not interfere in a CA-125 assay that uses OC-125 and M11 antibodies. , 1993, Clinical chemistry.

[41]  R. Ekins Immunoassay design and optimization , 1991 .

[42]  A. Killeen,et al.  High-Dose Hook Effect in an Immunoluminometric Thyrotropin Assay: The Open-Faced Sandwich Artefact , 1993, Annals of clinical biochemistry.

[43]  N. Yoshikawa,et al.  Plasma free thyroxine (FT4) concentrations during hemodialysis in patients with chronic renal failure: effects of plasma non-esterified fatty acids on FT4 measurement. , 1996, Endocrine journal.

[44]  Hammer Ej,et al.  Increase in serum testosterone following contact with blood cells , 1985 .

[45]  T. Lindahl,et al.  Chicken antibodies: a tool to avoid interference by complement activation in ELISA. , 1992, Journal of immunological methods.

[46]  R. Ekins Measurement of free hormones in blood. , 1990, Endocrine reviews.

[47]  D R Turner,et al.  Reappraisal of the causes of the "hook effect" in two-site immunoradiometric assays. , 1982, Analytical biochemistry.

[48]  P. Luppa,et al.  Effect of sex-hormone-binding globulin on no-extraction immunoassays for testosterone. , 1990, Clinical chemistry.

[49]  R. B. Wilcox,et al.  Dependence of free thyroxine estimates obtained with equilibrium tracer dialysis on the concentration of thyroxine-binding globulin. , 1992, Clinical chemistry.

[50]  J. Nurnberger,et al.  Factors that influence radioimmunoassay of human plasma melatonin: a modified column procedure to eliminate interference. , 1993, Biochemical Medicine and Metabolic Biology.

[51]  K. Nustad,et al.  A sequential binding assay with a working range extending beyond seven orders of magnitude. , 1995, Journal of immunological methods.

[52]  R. Swaminathan,et al.  The Contribution of Steroids to Digoxin-Like Immunoreactivity in Cord Blood , 1992, Annals of clinical biochemistry.

[53]  P. Bodlaender No SHBG interference with the "Coat-A-Count Total Testosterone" direct RIA kit. , 1990, Clinical chemistry.

[54]  W. G. Wood,et al.  "Matrix effects" in immunoassays. , 1991, Scandinavian journal of clinical and laboratory investigation. Supplementum.

[55]  J. Stockigt,et al.  "Unbound analog" radioimmunoassays for free thyroxin measure the albumin-bound hormone fraction. , 1983, Clinical chemistry.

[56]  N. Bhagavan,et al.  Familial dysalbuminemic hyperthyroxinemia: a study of four probands and the kindred of three. , 1984, Clinical chemistry.

[57]  A. Pakarinen,et al.  Effects of Drugs on Clinical Laboratory Tests , 1997, Annals of clinical biochemistry.

[58]  D Rodbard,et al.  Kinetics of two-site immunoradiometric ('sandwich') assays-II. Studies on the nature of the 'high-dose hook effect'. , 1978, Immunochemistry.

[59]  J. Cook,et al.  Measurement of serum ferritin by a 2-site immunoradiometric assay. , 1974, Analytical biochemistry.

[60]  M. F. Stewart,et al.  Thyroid Function Tests in Patients with Familial Dysalbuminaemic Hyperthyroxinaemia (FDH) , 1986, Annals of clinical biochemistry.

[61]  M. Nahm,et al.  Heteroantibody: phantom of the immunoassay. , 1990, Clinical chemistry.

[62]  J. M. Brooks,et al.  Elimination of "hook-effect" in two-site immunoradiometric assays by kinetic rate analysis. , 1984, Clinical chemistry.

[63]  B. Petersen,et al.  Quantitation of human anti-mouse antibody in serum by flow cytometry. , 1992, Cytometry.

[64]  N. Madry,et al.  Measures to overcome HAMA interferences in immunoassays. , 1997, Anticancer research.

[65]  L. Boscato,et al.  Incidence and specificity of interference in two-site immunoassays. , 1986, Clinical chemistry.

[66]  R. Nussenblatt,et al.  Intravenous fluorescein interference with clinical laboratory tests. , 1989, American journal of ophthalmology.

[67]  R. B. Wilcox,et al.  Underestimates of serum free thyroxine (T4) concentrations by free T4 immunoassays. , 1994, The Journal of clinical endocrinology and metabolism.

[68]  J. Tuttlebee Further Experience with Free Thyroxine Assays with Particular Reference to Pregnancy , 1982, Annals of clinical biochemistry.

[69]  I. Vermes,et al.  Interpretations of five monoclonal immunoassays of lutropin and follitropin: effects of normalization with WHO standard. , 1991, Clinical chemistry.

[70]  K. Yasuda,et al.  Prevalence of thyroid hormone autoantibodies in healthy subjects , 1994, Clinical endocrinology.

[71]  H. Ozaki,et al.  Reducing interference from heterophilic antibodies in a two-site immunoassay for carcinoembryonic antigen (CEA) by using a human/mouse chimeric antibody to CEA as the tracer. , 1995, Journal of immunological methods.

[72]  R. John,et al.  Antibody Interference in a Two-Site Immunometnc Assay for Thyrotrophin , 1989, Annals of clinical biochemistry.

[73]  E. Slaats,et al.  Interference of sex-hormone binding globulin in the "Coat-A-Count" testosterone no-extraction radioimmunoassay. , 1987, Clinical chemistry.

[74]  C. O’Farrelly,et al.  IgA rheumatoid factor and IgG dietary protein antibodies are associated in rheumatoid arthritis. , 1989, Immunological investigations.

[75]  M. Worwood,et al.  Antigen Binding in the Two-Site Immunoradiometric Assay for Serum Ferritin: The Nature of the Hook Effect , 1984, Annals of clinical biochemistry.

[76]  R. Heimer,et al.  Specificity of IgM antibodies to pooled human F(ab')2 fragments. , 1984, Immunological communications.

[77]  N. Bizzaro,et al.  Pitfalls in measuring lutropin by two-site immunoassay with monoclonal antibodies against the intact molecule. , 1992, Clinical chemistry.

[78]  S. Morrison,et al.  Production and characterization of genetically engineered antibody molecules. , 1988, Clinical chemistry.

[79]  L. Kricka,et al.  Interference by human anti-mouse antibody in two-site immunoassays. , 1990, Clinical chemistry.

[80]  D. Goldenberg,et al.  Solving the problem of antibody interference in commercial "sandwich"-type immunoassays of carcinoembryonic antigen. , 1989, Clinical chemistry.

[81]  J. Sgouris Limitations of the radioimmunoassay for hepatitis B antigen (HB Ag). , 1973, The New England journal of medicine.

[82]  R. Hähnel,et al.  Investigation of sex-hormone binding globulin interference in direct radioimmunoassays for testosterone and estradiol. , 1989, Clinical chemistry.

[83]  S. Bock,et al.  A study of serum antibodies to isolated milk proteins and ovalbumin in infants and children , 1977, Clinical allergy.

[84]  C. Cambiaso,et al.  Particle counting immunoassay (PACIA). , 1981, Methods in enzymology.

[85]  R. Lamerz,et al.  Value of HAMA--determination in clinical practice--an overview. , 1997, Anticancer research.

[86]  R. B. Wilcox,et al.  Analytical performance of free and total thyroxine assays. , 1996, Clinical chemistry.

[87]  N. Amino,et al.  Digoxin immunoassay that avoids cross-reactivity from Chinese medicines. , 1995, Clinical chemistry.

[88]  M. McConway,et al.  Discrepancies in hFSH Measurements by Two-Site IRMA in the Ovulatory Phase of the Menstrual Cycle , 1992, Annals of clinical biochemistry.

[89]  T. Mckenna,et al.  Multiple spuriously abnormal thyroid function indices due to heterophilic antibodies , 1994, Clinical endocrinology.

[90]  Saris Ne Provisional recommendation on quality control in clinical chemistry. , 1977, Clinica chimica acta; international journal of clinical chemistry.

[91]  L. Bartalena,et al.  Thyroid hormone transport proteins. , 1993, Clinics in laboratory medicine.

[92]  W. Jeffcoate,et al.  RADIOIMMUNOASSAY ARTIFACT ASSOCIATED WITH CIRCULATING ANTI‐RABBIT ANTIBODIES , 1988, Clinical endocrinology.

[93]  K. Ashwell,et al.  Serum Free Thyroxine Concentrations in Subjects with High Circulating Levels of Thyroxine-Binding Globulin , 1983, Annals of clinical biochemistry.

[94]  M. Zweig,et al.  Analytical interference caused by incompletely clotted serum specimens. , 1994, Clinical chemistry.

[95]  J. Ghali,et al.  A new interference in some digoxin assays: Anti‐murine heterophilic antibodies , 1996, Clinical pharmacology and therapeutics.

[96]  L. Cole,et al.  Polypeptide nicks cause erroneous results in assays of human chorionic gonadotropin free beta-subunit. , 1992, Clinical chemistry.

[97]  S. Refetoff Inherited thyroxine-binding globulin abnormalities in man. , 1989, Endocrine reviews.

[98]  J. Highton,et al.  A solid-phase enzyme immunoassay for C-reactive protein: clinical value and the effect of rheumatoid factor. , 1984, Journal of immunological methods.